Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free AREC Stock Alerts

Arecor Therapeutics (AREC) Competitors

Arecor Therapeutics logo
GBX 87.62 -0.88 (-0.99%)
As of 12:33 PM Eastern
Compare

AREC vs. BKY, AURA, NEO, NCCL, and ARMS

Should you buy Arecor Therapeutics stock or one of its competitors? Arecor Therapeutics's main competitors and comparable companies include Berkeley Energia (BKY), Aura Energy (AURA), Neo Energy Metals (NEO), Ncondezi Energy (NCCL), and Asia Resource Minerals (ARMS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "coal & consumable fuels" industry.

How does Arecor Therapeutics compare to Berkeley Energia?

Berkeley Energia (LON:BKY) and Arecor Therapeutics (LON:AREC) are both small-cap energy companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

In the previous week, Berkeley Energia's average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Berkeley Energia Neutral
Arecor Therapeutics Neutral

Berkeley Energia has higher revenue and earnings than Arecor Therapeutics. Berkeley Energia is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Berkeley Energia£2.11M50.69-£6.48M-£1.95N/A
Arecor Therapeutics£1.71M19.30-£10.68M£2.0043.81

Berkeley Energia has a beta of 1.138, indicating that its share price is 14% more volatile than the broader market. Comparatively, Arecor Therapeutics has a beta of -0.18, indicating that its share price is 118% less volatile than the broader market.

Arecor Therapeutics has a net margin of 38.74% compared to Berkeley Energia's net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Berkeley Energia's return on equity.

Company Net Margins Return on Equity Return on Assets
Berkeley EnergiaN/A -11.86% -4.29%
Arecor Therapeutics 38.74%14.26%-37.31%

20.7% of Berkeley Energia shares are held by institutional investors. Comparatively, 6.7% of Arecor Therapeutics shares are held by institutional investors. 10.0% of Berkeley Energia shares are held by company insiders. Comparatively, 4.8% of Arecor Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Berkeley Energia beats Arecor Therapeutics on 7 of the 11 factors compared between the two stocks.

How does Arecor Therapeutics compare to Aura Energy?

Aura Energy (LON:AURA) and Arecor Therapeutics (LON:AREC) are both small-cap energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

Aura Energy has a beta of -0.35, suggesting that its share price is 135% less volatile than the broader market. Comparatively, Arecor Therapeutics has a beta of -0.18, suggesting that its share price is 118% less volatile than the broader market.

In the previous week, Aura Energy's average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Aura Energy Neutral
Arecor Therapeutics Neutral

Arecor Therapeutics has a net margin of 38.74% compared to Aura Energy's net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Aura Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Aura EnergyN/A -17.87% -8.03%
Arecor Therapeutics 38.74%14.26%-37.31%

11.3% of Aura Energy shares are held by institutional investors. Comparatively, 6.7% of Arecor Therapeutics shares are held by institutional investors. 5.9% of Aura Energy shares are held by company insiders. Comparatively, 4.8% of Arecor Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Aura Energy has higher earnings, but lower revenue than Arecor Therapeutics. Aura Energy is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aura EnergyN/AN/A-£16.15K-£1.11N/A
Arecor Therapeutics£1.71M19.30-£10.68M£2.0043.81

Summary

Arecor Therapeutics beats Aura Energy on 6 of the 10 factors compared between the two stocks.

How does Arecor Therapeutics compare to Neo Energy Metals?

Arecor Therapeutics (LON:AREC) and Neo Energy Metals (LON:NEO) are both small-cap energy companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Arecor Therapeutics has a beta of -0.18, meaning that its stock price is 118% less volatile than the broader market. Comparatively, Neo Energy Metals has a beta of 4.985, meaning that its stock price is 399% more volatile than the broader market.

In the previous week, Arecor Therapeutics' average media sentiment score of 0.00 equaled Neo Energy Metals'average media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Neo Energy Metals Neutral

Neo Energy Metals has lower revenue, but higher earnings than Arecor Therapeutics. Neo Energy Metals is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£1.71M19.30-£10.68M£2.0043.81
Neo Energy MetalsN/AN/A-£4.24M£0.183.90

6.7% of Arecor Therapeutics shares are owned by institutional investors. Comparatively, 3.7% of Neo Energy Metals shares are owned by institutional investors. 4.8% of Arecor Therapeutics shares are owned by company insiders. Comparatively, 40.4% of Neo Energy Metals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Arecor Therapeutics has a net margin of 38.74% compared to Neo Energy Metals' net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Neo Energy Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics38.74% 14.26% -37.31%
Neo Energy Metals N/A -503.60%N/A

Summary

Arecor Therapeutics beats Neo Energy Metals on 6 of the 10 factors compared between the two stocks.

How does Arecor Therapeutics compare to Ncondezi Energy?

Arecor Therapeutics (LON:AREC) and Ncondezi Energy (LON:NCCL) are both small-cap energy companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

Ncondezi Energy has lower revenue, but higher earnings than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£1.71M19.30-£10.68M£2.0043.81
Ncondezi EnergyN/AN/A-£2.05MN/AN/A

Arecor Therapeutics has a net margin of 38.74% compared to Ncondezi Energy's net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Ncondezi Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics38.74% 14.26% -37.31%
Ncondezi Energy N/A -15.23%-5.36%

Arecor Therapeutics has a beta of -0.18, indicating that its share price is 118% less volatile than the broader market. Comparatively, Ncondezi Energy has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

6.7% of Arecor Therapeutics shares are held by institutional investors. Comparatively, 9.7% of Ncondezi Energy shares are held by institutional investors. 4.8% of Arecor Therapeutics shares are held by insiders. Comparatively, 34.3% of Ncondezi Energy shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Arecor Therapeutics' average media sentiment score of 0.00 equaled Ncondezi Energy'saverage media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Ncondezi Energy Neutral

Summary

Ncondezi Energy beats Arecor Therapeutics on 5 of the 9 factors compared between the two stocks.

How does Arecor Therapeutics compare to Asia Resource Minerals?

Asia Resource Minerals (LON:ARMS) and Arecor Therapeutics (LON:AREC) are both energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

In the previous week, Asia Resource Minerals' average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Asia Resource Minerals Neutral
Arecor Therapeutics Neutral

6.7% of Arecor Therapeutics shares are held by institutional investors. 4.8% of Arecor Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Arecor Therapeutics has a net margin of 38.74% compared to Asia Resource Minerals' net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Asia Resource Minerals' return on equity.

Company Net Margins Return on Equity Return on Assets
Asia Resource MineralsN/A N/A N/A
Arecor Therapeutics 38.74%14.26%-37.31%

Asia Resource Minerals has higher earnings, but lower revenue than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Asia Resource MineralsN/AN/AN/AN/AN/A
Arecor Therapeutics£1.71M19.30-£10.68M£2.0043.81

Summary

Arecor Therapeutics beats Asia Resource Minerals on 5 of the 6 factors compared between the two stocks.

Get Arecor Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AREC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AREC vs. The Competition

Export
MetricArecor TherapeuticsOil, Gas & Consumable Fuels IndustryEnergy SectorLON Exchange
Market Cap£33.09M£11.21B£9.79B£2.88B
Dividend YieldN/A10.24%10.69%6.22%
P/E Ratio43.8116.4819.20365.96
Price / Sales19.30674.82550.7089,730.92
Price / Cash5.0740.9436.9627.89
Price / Book5.284.413.976.33
Net Income-£10.68M£5.28B£4.35B£5.89B
7 Day Performance0.02%-2.10%-2.17%-0.12%
1 Month Performance19.22%-0.68%-1.28%11.00%
1 Year Performance0.21%26.55%27.55%18.40%

Arecor Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AREC
Arecor Therapeutics
N/AGBX 87.63
-1.0%		N/A-0.2%£33.09M£1.71M43.8110
BKY
Berkeley Energia
N/AGBX 26
flat		N/A-4.3%£116.04M£2.11MN/AN/A
AURA
Aura Energy
N/AGBX 5.83
+1.3%		N/A-56.9%£59.38MN/AN/A50
NEO
Neo Energy Metals
N/AGBX 0.87
-3.4%		N/AN/A£24.53MN/A4.772,100
NCCL
Ncondezi Energy
N/AN/AN/AN/A£4.67MN/AN/A4

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:AREC) was last updated on 9/29/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel